Ovulation Induction with Urinary and Recombinant FSH: Comparing Pregnancy Rate in Infertile Patients with Polycystic Ovary Syndrome
DOI:
https://doi.org/10.22100/jkh.v9i4.394Keywords:
Recombinant FSH, Urinary FSH, Polycystic ovary syndrome, Pregnancy.Abstract
Introduction: One of the causes of infertility is anovulation due to polycystic ovary syndrome (PCOS). In women with PCOS, Elevated serum LH levels and an increased ratio of LH to FSH is generally seen. To prevent an increase in LH and follicular atresia, the use of FSH is proposed. The aim of the present study was to compare pregnancy rate of two regimens of recombinant FSH (r-FSH) and urinary FSH (u-FSH) in patients with PCOS under IUI.
Methods: This is a descriptive- analytical (retrospective) study which conducted on 441 infertile women with PCOS that referred to infertility clinic of Kashan Shahid Beheshti Hospital (in two years), and met the inclusion criteria for the study; the data was collected by referring to patients’ files.
Results: there was no significant difference between the two groups in the mean endometrial thickness, number of dominant follicles, gonadotropin consumption, duration and type of infertility. Pregnancy rates in patients treated with the u-FSH was 6.28% and in the patients treated with r-FSH was 9.30%, and the difference was not statistically significant (P=0.59).
Conclusion: The results of this study showed that the there is no difference in terms of pregnancy rate between two products, u-FSH and r-FSH, in infertile patients with PCOS under IUI. Therefore, we can use both of these products according to availability, cost and patient acceptance.
References
Speroff L, Fritz M. Clinical gynecologic endocrinology and infertility. 8th ed Philadelphia,PA: Lippincott Williams and Wilkins;2011.p.1137-91.
Speroff L, Fritz M. Clinical gynecologic endocrinology and infertility. 8th ed. Philadelphia,PA:Lippincott Williams and Wilkins;2011.p.495-533.
Gerli S, Casini M, Unfer V, Costabile L, Mignosa M, Direnzo G. Ovulation induction with urinary FSH or recombinant FSH in polycystic ovary syndrome patients: a prospective randomized analysis of cost-effectiveness. Reproductive BioMedicine Online. 2004;9(5):494-9.
Gerli S, Casini L, Unfer V, Costabile L, Bini V, Direnzo G. Recombinant versus urinary folliclestimulating hormone in intrauterine insemination cycles: a prospective,randomized analysis of cost effectiveness. Fertility AND Sterility 2004;83(3):573-8.
Matorras R, RecioV, Corcostegui B, Rodriguer-Escudero FJ. Recombinant human FSH versus highly purified urinary FSH:a randomized study in intrauterine insemination with husband's spermatozoa. Human Reproduction 2000;15(6):1231-4.
Demirol A, Gurgan T. Comparison of different gonadotrophin preparations in intrauterine insemination cycles for the treatment of unexplained infertility: a prospective, randomized study. Human Reproduction 2007;22(1):97-100.
Balen A, Platteau P, Andersen AN, Devroey P, Helmgaard L, Arce JC, et al. Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomized controlled non-inferiority trial. Human Reproduction 2007;22(7):1816-23.
Demirol A, Gurgan T. Comparison of different gonadotrophin preparations in intrauterine insemination cycles for the treatment of unexplained infertility: a prospective, randomized study. Human Reproduction 2007;22(1):97-100.
Sohrabvand F, Sheikhhassani S, Bagheri M, Haghollahi F, Shabihkhani M, Shariat M, et al. Comparison of highly purified urinary versus recombinant FSH: Effect on ART outcomes in polycystic ovary syndrome. Iran J Reprod 2012;10(3):36-229.[Persian].
Revelli A, Poso F, Gennarelli G, Moffa F, Grassi G, Massobrio M. Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis. Reprod Biol Endocrinol 2006;4:38.
Mohamed MA, Sbracia M, Pacchiarotti A, Micara G, Linari A, Tranquilli D, et al. Urinary follicle-stimulating hormone (FSH) is more effective than recombinant FSH in older women in a controlled randomized study. Fertil Steril 2006;85(5):1398-403.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
